Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors
- PMID: 10339477
Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors
Abstract
The effects of thrombopoietin (TPO) and/or stem cell factor (SCF) on the development of human mast cells from CD34(+) bone marrow (BM) cells were investigated using a serum-deprived liquid culture system. Mast cells were identified by measurement of intracellular histamine content, immunocytochemical staining, and flow cytometric analysis. Whereas SCF alone generated only a small number of tryptase+ cells, the addition of TPO to the culture containing SCF resulted in an apparent production of mast cells from 3 weeks until at least 15 weeks. Some of the cells reacted with an antichymase monoclonal antibody as well. Based on the effects of growth factor(s) on a later phase of the mast cell growth, TPO may stimulate an early stage of mast cell development in combination with SCF, whereas subsequent growth seems to be supported by SCF alone. Single-cell culture studies indicated that the CD34(+)CD38(-)c-kit+ cells and CD34(+)CD38(+)c-kit+ cells were responsible for the SCF + TPO-dependent mast cell production. Two-step culture assays clearly showed that mast cells originated from multilineage colony-forming cells that had potential to differentiate into neutrophil/mast cell lineages, neutrophil/macrophage/mast cell lineages, or neutrophil/macrophage/mast cell/erythroid lineages. These results suggest that TPO plays an important role in the development of human mast cells from CD34(+) BM cells in concert with SCF, and provide direct evidence of the differentiation into the mast cell lineage of human multipotential BM-derived progenitors.
Similar articles
-
Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.Blood. 1999 Jan 15;93(2):509-18. Blood. 1999. PMID: 9885212
-
Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.J Leukoc Biol. 2000 Jul;68(1):137-43. J Leukoc Biol. 2000. PMID: 10914501
-
Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia.Blood. 1998 Jun 1;91(11):4065-73. Blood. 1998. PMID: 9596651
-
Regulation of mast cell development.Chem Immunol Allergy. 2005;87:1-21. doi: 10.1159/000087566. Chem Immunol Allergy. 2005. PMID: 16107759 Review.
-
Quantitative assessment of the stem cell self-renewal capacity.Ann N Y Acad Sci. 2001 Jun;938:18-24; discussion 24-5. doi: 10.1111/j.1749-6632.2001.tb03570.x. Ann N Y Acad Sci. 2001. PMID: 11458506 Review.
Cited by
-
Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.J Clin Invest. 2001 Oct;108(8):1195-204. doi: 10.1172/JCI13030. J Clin Invest. 2001. PMID: 11602627 Free PMC article.
-
Tumor associated mast cells: biological roles and therapeutic applications.Anat Cell Biol. 2020 Sep 30;53(3):245-251. doi: 10.5115/acb.19.181. Anat Cell Biol. 2020. PMID: 32879056 Free PMC article. Review.
-
Increased differentiation of dermal mast cells in mice lacking the Mpl gene.Stem Cells Dev. 2009 Sep;18(7):1081-92. doi: 10.1089/scd.2008.0323. Stem Cells Dev. 2009. PMID: 19025339 Free PMC article.
-
Development, migration, and survival of mast cells.Immunol Res. 2006;34(2):97-115. doi: 10.1385/IR:34:2:97. Immunol Res. 2006. PMID: 16760571 Free PMC article. Review.
-
KIT signaling is dispensable for human mast cell progenitor development.Blood. 2017 Oct 19;130(16):1785-1794. doi: 10.1182/blood-2017-03-773374. Epub 2017 Aug 8. Blood. 2017. PMID: 28790106 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials